Biogen’s multiple sclerosis franchise has been handed a boost with the US approval of Vumerity, a follow-up to its blockbuster Tecfidera that promises to be less likely to cause gastrointestinal ...

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke Therapeutics in a deal that included an upfront payment of $165 ...

Topo Designs As its name suggests, this new bag is a reinterpretation of the Topo Designs Rover Pack, one of the brand’s most popular and best-selling products. Interestingly, that original pack was ...